A
Ashita Tolwani
Researcher at University of Alabama at Birmingham
Publications - 111
Citations - 11076
Ashita Tolwani is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Renal replacement therapy & Acute kidney injury. The author has an hindex of 35, co-authored 101 publications receiving 9498 citations. Previous affiliations of Ashita Tolwani include University of Alabama.
Papers
More filters
Journal ArticleDOI
Acute Renal Failure in Critically Ill Patients: A Multinational, Multicenter Study
Shigehiko Uchino,John A. Kellum,Rinaldo Bellomo,Gordon S. Doig,Hiroshi Morimatsu,Stanislao Morgera,Miet Schetz,Ian Tan,Catherine S. C. Bouman,Ettiene Macedo,Noel Gibney,Ashita Tolwani,Claudio Ronco +12 more
TL;DR: In this article, the period prevalence of acute renal failure (ARF) requiring renal replacement therapy (RRT) was found to be between 5% and 6% and was associated with a high hospital mortality rate.
Journal ArticleDOI
Septic Acute Kidney Injury in Critically Ill Patients: Clinical Characteristics and Outcomes
Sean M. Bagshaw,Sean M. Bagshaw,Shigehiko Uchino,Shigehiko Uchino,Rinaldo Bellomo,Hiroshi Morimatsu,Stanislao Morgera,Miet Schetz,Ian Tan,Catherine S. C. Bouman,Ettiene Macedo,Noel Gibney,Ashita Tolwani,Heleen M. Oudemans-van Straaten,Claudio Ronco,John A. Kellum +15 more
TL;DR: Patients with septic AKI had an increased risk for death and longer duration of hospitalization yet showed trends toward greater renal recovery and independence from RRT.
Journal ArticleDOI
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury
Paul M. Palevsky,Kathleen D. Liu,Patrick D. Brophy,Lakhmir S. Chawla,Chirag R. Parikh,Charuhas V. Thakar,Ashita Tolwani,Sushrut S. Waikar,Steven D. Weisbord +8 more
TL;DR: A group of US experts in adult and pediatric AKI and critical care nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns concluded that there is insufficient evidence to support their widespread application to clinical care in the United States.
Journal ArticleDOI
Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators
Shigehiko Uchino,Rinaldo Bellomo,Hiroshi Morimatsu,Stanislao Morgera,Miet Schetz,Ian Tan,Catherine S. C. Bouman,Ettiene Macedo,Noel Gibney,Ashita Tolwani,Heleen M. Oudemans-van Straaten,Claudio Ronco,John A. Kellum +12 more
TL;DR: This study supports the notion that, worldwide, CRRT practice is quite variable and not aligned with best evidence.
Journal ArticleDOI
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.
Mitra K. Nadim,Lui G. Forni,Lui G. Forni,Ravindra L. Mehta,Michael J. Connor,Kathleen D. Liu,Marlies Ostermann,Thomas Rimmelé,Alexander Zarbock,Samira Bell,Azra Bihorac,Vincenzo Cantaluppi,Eric Hoste,Faeq Husain-Syed,Michael J. Germain,Stuart L. Goldstein,Shruti Gupta,Michael Joannidis,Kianoush Kashani,Jay L. Koyner,Matthieu Legrand,Nuttha Lumlertgul,Sumit Mohan,Neesh Pannu,Zhiyong Peng,Xose L. Perez-Fernandez,Peter Pickkers,John R. Prowle,Thiago Reis,Nattachai Srisawat,Nattachai Srisawat,Ashita Tolwani,Anitha Vijayan,Gianluca Villa,Li Yang,Claudio Ronco,John A. Kellum +36 more
TL;DR: This Consensus Statement from the Acute Disease Quality Initiative provides recommendations for the diagnosis, prevention and management of COVID-19 AKI and for areas of future research, with the aim of improving understanding of the underlying processes and outcomes for patients with CO VID- 19 AKI.